Ronda Scott v. Advanced Pharmaceutical Consultants Inc

84 F.4th 952
Court of Appeals for the Eleventh Circuit·Decided October 17, 2023·No. 21-14214·Published·Cited by 8 cases

Opinion

[PUBLISH]

In the

United States Court of Appeals For the Eleventh Circuit

No. 21-14214

RONDA SCOTT, Plaintiff-Appellant

Cross Appellee,

versus ADVANCED PHARMACEUTICAL CONSULTANTS, INC.,

Defendant-Appellee,

CENTURION OF FLORIDA, LLC,

Defendant-Appellee

Cross Appellant.

2 Opinion of the Court 21-14214

Appeal from the United States District Court for the Northern District of Florida D.C. Docket No. 5:19-cv-00571-RH-MJF

Before WILLIAM PRYOR, Chief Judge, and LUCK and MARCUS, Circuit Judges. MARCUS, Circuit Judge:

At its simplest, this case is about whether Ronda Scott was retaliated against by her former employer, Advanced Pharmaceutical Consultants, Inc. (“APC”), and the company that contracted with her employer, Centurion of Florida, LLC (“Centurion”) (together , “Defendants”), for engaging in protected activity. But, as it turns out, we are without power to decide that question because we lack jurisdiction to entertain this interlocutory appeal.

APC fired Scott in September 2018. Scott alleges it was because she reported to Centurion and APC that some of Centurion’s prison pharmacies were logging Epclusa, a drug used to treat hepatitis C, as a narcotic even though it is not one, and because she complained about dangerous “staff turnover” contributing to a “complete system breakdown” in one prison. Scott claims that this activity was legally protected, so she sued Centurion and APC in the United States District Court for the Northern District of Florida in late December 2019. Her complaint alleged four counts: violations of the Florida Private Whistleblower Act (“FPWA”) and

21-14214 Opinion of the Court 3

Florida Public Whistleblower Act (“FWA”) against Centurion and APC, and violations of the False Claims Act (“FCA”) and intentional interference with her advantageous business relations (“tortious interference”) against Centurion.

Centurion and APC both moved for summary judgment on all counts. The district court granted summary judgment on three of them -- the FPWA, FWA, and FCA counts -- but denied summary judgment on the tortious interference count. Pursuant to Federal Rule of Civil Procedure 54(b), the district court directed the clerk to enter a final judgment on the three resolved counts, and it certi- fied that the fourth count satisfied the requirements of 28 U.S.C. § 1292(b) for immediate interlocutory review, should either party file an appropriate application with this Court. We must now decide whether the district court’s certification was proper as to Scott’s direct appeal, and whether the requirements of 28 U.S.C. § 1292(b) have been met as to Centurion’s cross appeal.

After careful review and with the benefit of oral argument, we conclude that the answer to both questions is no. We therefore dismiss the appeals for lack of appellate jurisdiction.

I.

Centurion contracted with the Florida Department of Corrections to supply health care services to inmates in some Florida prisons. The contract required Centurion to engage a subcontractor to “provide certain consultant pharmacy services” to those prisons . To fulfill this obligation, Centurion hired APC as an independent contractor.

4 Opinion of the Court 21-14214

Scott formerly worked for APC as a regional consultant pharmacist. Among other things, she oversaw the pharmacies in several Centurion-serviced prisons to ensure compliance with applicable laws, rules, and regulations. APC fired Scott on September 10, 2018. Scott alleges it was because she spoke about the serious conditions that she found at the prisons.

First, on May 16, 2018, Scott noted on Centurion’s required Continuous Quality Improvement (“CQI”) form that she observed a “complete system breakdown -- staff turnover.” Scott explained that she made these comments to document her belief that licensed personnel were being replaced by unlicensed personnel in the pharmacy and that unlicensed personnel were performing tasks that could not be performed without a license. Scott also complained that inventory was not correct for certain medications and that some doses and documentation were missing, specifically for Epclusa, a medication used to treat hepatitis C. Scott testified that this visit was “probably the worst [she had] ever seen [at] a facility since [she] was promoted to the position as consultant pharmacist” and that she thought “the pharmacy permit could have been easily revoked on that day.”

Centurion disagreed with Scott’s comments and asked her to change them on the CQI form. Centurion told her that she did not need to log Epclusa because it was being monitored separately pursuant to a court order. And Centurion thought the “complete system breakdown” language was unfair, unprofessional, and not responsive to the information requested by the CQI form. Scott

21-14214 Opinion of the Court 5

complied and amended the CQI form even though she didn’t want to. After changing the CQI form, Scott contacted the Department of Health to ask if her license would be jeopardized if “another accreditation agency inspected the facility” and disagreed with the amended findings.

Scott continued to raise concerns about Epclusa in subsequent prison visits. Centurion grew frustrated and asked APC if Scott could be replaced with another consultant pharmacist. APC counseled Scott about her performance, but Scott said that she felt she was being targeted and discriminated against. Scott was issued a final written warning by APC for work performance issues on August 29, 2018. According to APC, Scott then failed to appear at work as scheduled on two occasions. As a result of these and other “performance issues,” Scott was fired a short time later.

Believing her termination to be a form of retaliation for speaking out, Scott initiated this action by filing a complaint in the Northern District of Florida on December 27, 2019. Her complaint alleged four counts: two whistleblower retaliation counts against both Defendants under the FPWA and FWA, and a retaliation count under the FCA and a common law tortious interference count against only Centurion. The complaint contained a single “prayer of relief ” requesting compensatory damages, injunctive relief , prejudgment interest, attorney’s fees and costs, and punitive damages “on all claims on which such damages may be presently asserted.” The complaint did not indicate whether each form of

6 Opinion of the Court 21-14214

relief is specific to a particular count, other than asserting that compensatory damages are sought “on all Counts.”

Defendants moved for summary judgment across the board.

The district court granted summary judgment on three of the four counts but left the tortious interference count open and outstanding . In an amended summary judgment order, the district court directed the clerk to enter a partial final judgment under Federal Rule of Civil Procedure 54(b) “on the claims resolved by th[e] order .” The trial court also certified that the still-pending tortious interference count satisfied the requirements of 28 U.S.C. § 1292(b).

Scott timely appealed the district court’s grant of summary judgment on the FPWA and FWA counts. Scott did not, however, appeal the entry of summary judgment in favor of Centurion on the FCA count. Centurion, in turn, cross appealed the district court’s denial of summary judgment on the tortious interference count.

II.

A certification under Rule 54(b) implicates the scope of our appellate jurisdiction, so we must consider that issue sua sponte. Ebrahimi v. City of Huntsville Bd. of Educ., 114 F.3d 162, 165 (11th Cir. 1997) (per curiam). Rule 54(b) reads this way:

When an action presents more than one claim for relief -- whether as a claim, counterclaim, crossclaim, or third-party claim -- or when multiple parties are involved , the court may direct entry of a final judgment

21-14214 Opinion of the Court 7

Free access — add to your briefcase to read the full text and ask questions with AI

Ronda Scott v. Advanced Pharmaceutical Consultants Inc, 84 F.4th 952 (11th Cir. 2023).

84 F.4th 952 (Ronda Scott v. Advanced Pharmaceutical Consultants Inc) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related